Skandinaviska Enskilda Banken (SEB)’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-87,185
Closed -$17.9M 248
2025
Q4
$17.9M Buy
87,185
+20,806
+31% +$3.92M 0.07% 194
2025
Q3
$10.4M Sell
66,379
-13,909
-17% -$2.15M 0.04% 273
2025
Q2
$13.5M Sell
80,288
-25,248
-24% -$3.75M 0.06% 241
2025
Q1
$14.5M Sell
105,536
-271,581
-72% -$34.6M 0.07% 222
2024
Q4
$44.5M Sell
377,117
-94,271
-20% -$11M 0.2% 89
2024
Q3
$52.1M Sell
471,388
-360,197
-43% -$37.7M 0.24% 75
2024
Q2
$81.8M Sell
831,585
-166,302
-17% -$16.9M 0.39% 47
2024
Q1
$112M Buy
997,887
+369,965
+59% +$39.9M 0.55% 31
2023
Q4
$63.3M Buy
627,922
+196,965
+46% +$19.5M 0.37% 50
2023
Q3
$37.4M Buy
430,957
+70,030
+19% +$6.33M 0.25% 79
2023
Q2
$34.1M Buy
360,927
+177,828
+97% +$15M 0.22% 92
2023
Q1
$13.8M Buy
183,099
+134,310
+275% +$10.1M 0.1% 223
2022
Q4
$3.75M Buy
48,789
+3,718
+8% +$283K 0.03% 411
2022
Q3
$3M Sell
45,071
-2,695
-6% -$171K 0.02% 458
2022
Q2
$2.5M Sell
47,766
-946
-2% -$53.8K 0.02% 515
2022
Q1
$2.76M Sell
48,712
-2,245
-4% -$120K 0.02% 543
2021
Q4
$2.66M Sell
50,957
-1,881
-4% -$92.3K 0.01% 580
2021
Q3
$2.61M Sell
52,838
-5
-0% -$271 0.01% 576
2021
Q2
$3.02M Sell
52,843
-13,481
-20% -$788K 0.02% 554
2021
Q1
$4.03M Buy
66,324
+13,405
+25% +$740K 0.03% 444
2020
Q4
$2.83M Sell
52,919
-12,212
-19% -$634K 0.02% 522
2020
Q3
$3.06M Sell
65,131
-140,938
-68% -$7.23M 0.02% 445
2020
Q2
$10.8M Sell
206,069
-14,871
-7% -$767K 0.09% 212
2020
Q1
$10.6M Sell
220,940
-52,713
-19% -$2.74M 0.11% 176
2019
Q4
$13.8M Sell
273,653
-78,914
-22% -$4.08M 0.11% 174
2019
Q3
$16.6M Sell
352,567
-1,222,101
-78% -$55.8M 0.14% 141
2019
Q2
$74.2M Buy
1,574,668
+105,389
+7% +$4.86M 0.64% 33
2019
Q1
$70.7M Buy
1,469,279
+1,415,551
+2,635% +$70.9M 0.65% 37
2018
Q4
$2.4M Sell
53,728
-5,564
-9% -$290K 0.02% 428
2018
Q3
$3.2M Sell
59,292
-300
-0.5% -$15.4K 0.02% 386
2018
Q2
$2.91M Buy
59,592
+20,302
+52% +$1.15M 0.02% 357
2018
Q1
$2.46M Sell
39,290
-24,279
-38% -$1.67M 0.02% 345
2017
Q4
$3.9M Buy
63,569
+8,317
+15% +$514K 0.03% 323
2017
Q3
$3.7M Sell
55,252
-116,600
-68% -$8.24M 0.03% 343
2017
Q2
$13.4M Sell
171,852
-1,200
-0.7% -$90.6K 0.13% 157
2017
Q1
$14.1M Sell
173,052
-2,015
-1% -$159K 0.14% 134
2016
Q4
$12.6M Buy
175,067
+1,235
+0.7% +$89.3K 0.15% 116
2016
Q3
$13.5M Sell
173,832
-413,900
-70% -$33.4M 0.15% 115
2016
Q2
$45.8M Sell
587,732
-13,800
-2% -$1.1M 0.51% 39
2016
Q1
$49.3M Sell
601,532
-4,800
-0.8% -$390K 0.55% 34
2015
Q4
$54.1M Buy
+606,332
New +$51.5M 0.7% 29

Other funds holding CAH

Skandinaviska Enskilda Banken (SEB)'s CAH Position: Q1 2026 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Cardinal Health (CAH) in Q1 2026, closing a stake of 87,185 shares — an estimated $17.9M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in CAH in Q4 2015 and held it in 41 quarters. The position peaked at $112M in Q1 2024. 1,426 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Cardinal Health position as of Q1 2026 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 87,185 Cardinal Health shares in Q1 2026, an estimated $17.9M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Cardinal Health in Q4 2015 and held it in 41 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Cardinal Health position peaked at $112M in Q1 2024.
  • 1,426 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2026, filed 15 May 2026.